Anakinra as first-line monotherapy for new-onset steroid-naïve sJIA patients.

Overview publication

TitleAnakinra as first-line monotherapy for new-onset steroid-naïve sJIA patients.
Date2024-11-01
Issue nameExpert review of clinical immunology
Issue numberv20.11:1293-1295
DOI10.1080/1744666X.2024.2384703
PubMed39041826
AuthorsMastrolia MV, Abu-Rumeileh S, Maccora I, Maniscalco V, Marrani E, Pagnini I, Taddio A & Simonini G
Keywordsanakinra, steroid naïve, systemic idiopathic juvenile arthritis, window of opportunity
Read Read publication